Nasopharyngitis | List of Frontiers open access articles

Original Research

Published on 14 Feb 2022

Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma

in Head and Neck Cancer

Danxian Jiang
Yin Li
Jinxin Cao
Lianghe Sheng
Xinhai Zhu
Meng Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.779175

4,543 views
17 citations

Original Research

Published on 23 May 2022

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis

in Head and Neck Cancer

Guihua Zhong
Wei Wei
Wei Liao
Rong Wang
Yingpeng Peng
Yuling Zhou
Xiaotao Huang
Shiping Xian
Shunli Peng
Zhaoyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.859721

6,277 views
18 citations

Original Research

Published on 10 Jun 2024

Causal associations between pediatric asthma and united airways disease: a two-sample Mendelian randomization analysis

in Pulmonary Medicine

Tongxun Gao
Qiuhan Cai
Siyuan Hu
Rongxin Zhu
Jixuan Wang

Frontiers in Medicine

doi 10.3389/fmed.2024.1369695

3,444 views
1 citation

Systematic Review

Published on 13 May 2021

Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Movement Disorders

Shujun Chen
Tianyu Liang
Tao Xue
Shouru Xue
Qun Xue

Frontiers in Neurology

doi 10.3389/fneur.2021.658123

8,997 views
13 citations

Original Research

Published on 22 Jul 2024

Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study

in Neuromuscular Disorders and Peripheral Neuropathies

Thomas O. Crawford
John W. Day
Darryl C. De Vivo
Jena M. Krueger
Eugenio Mercuri
Andres Nascimento
Amy Pasternak
Elena Stacy Mazzone
Tina Duong
Guochen Song

Frontiers in Neurology

doi 10.3389/fneur.2024.1419791

11,894 views
13 citations

Original Research

Published on 26 Oct 2023

Big data- and machine learning-based analysis of a global pharmacovigilance database enables the discovery of sex-specific differences in the safety profile of dual IL4/IL13 blockade

in Pharmacoepidemiology

Kassem Sharif
Mahmud Omar
Adi Lahat
Yonatan Shneor Patt
Howard Amital
Ghanem Zoabi
Nicola Luigi Bragazzi
Abdulla Watad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1271309

4,247 views
3 citations

Systematic Review

Published on 23 Sep 2022

Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Zhihui Liu
Ruijuan Cheng
Yi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.996662

12,157 views
16 citations

Original Research

Published on 17 Aug 2023

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib

in Gastrointestinal and Hepatic Pharmacology

Yan Wu
Meihao Wei
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200254

9,285 views
23 citations

Systematic Review

Published on 25 Feb 2022

A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis

in Dermatology

Francisco Gómez-García
Pedro Jesús Gómez-Arias
Ana Montilla-López
Jorge Hernández-Parada
Juan Luís Sanz-Cabanillas
Juan Ruano
Esmeralda Parra-Peralbo

Frontiers in Medicine

doi 10.3389/fmed.2022.754116

12,017 views
27 citations

Clinical Trial

Published on 17 Jan 2024

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

in Neuromuscular Disorders and Peripheral Neuropathies

James F. Howard
Vera Bril
Tuan Vu
Chafic Karam
Stojan Peric
Jan L. De Bleecker
Hiroyuki Murai
Andreas Meisel
Said R. Beydoun
Mamatha Pasnoor

Frontiers in Neurology

doi 10.3389/fneur.2023.1284444

35,928 views
59 citations

Systematic Review

Published on 10 Nov 2023

Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials

in Clinical Diabetes

Lu Chen
Qingxia Xue
Chunyan Yan
Bingying Tang
Lu Wang
Bei Zhang
Quan Zhao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1256548

9,929 views
14 citations

Systematic Review

Published on 31 Jan 2023

Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review

in Cytokines and Soluble Mediators in Immunity

Jiao Wang
Chunxiao Wang
Liu Liu
Seokgyeong Hong
Yi Ru
Xiaoying Sun
Jiale Chen
Miao Zhang
Naixuan Lin
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.993057

19,652 views
37 citations

Original Research

Published on 03 Mar 2025

Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus – a phase 4 study in India

in Clinical Diabetes

S. K. Wangnoo
Sanjay Kumar Bhadada
Faraz Farishta
Girithara Gopalakrishnan Jayaram Naidu
Indira Pattnaik
K. N. Manohar
K. P. Singh
Sandeep Kumar Gupta
H. S. Bharath
Sujoy Ghosh

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1528801

4,910 views

Systematic Review

Published on 09 Sep 2024

Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Jingyue Qiu
Jiakuo Liu
Kexin Cai
Ting Xu
Wenwen Liu
Fei Lin
Ning Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420455

6,229 views
9 citations

Systematic Review

Published on 18 Sep 2025

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Shan Gao
Xingxing Xie
Ling Fan
Linyuan Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654343

9,554 views
5 citations

Systematic Review

Published on 29 Jan 2024

First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis

in Clinical Diabetes

Rui Deng
Kaibo Mei
Tiangang Song
Jinyi Huang
Yifan Wu
Peng Yu
Zhiwei Yan
Xiao Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1289643

7,833 views
4 citations

Articles

Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis

Causal associations between pediatric asthma and united airways disease: a two-sample Mendelian randomization analysis

Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study

Big data- and machine learning-based analysis of a global pharmacovigilance database enables the discovery of sex-specific differences in the safety profile of dual IL4/IL13 blockade

Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib

A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials

Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review

Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus – a phase 4 study in India

Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials

First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis